Search Results
Results found for "Dr. Juan Jose Fung"
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- The Five Traps of Ignoring Kinetics
of max in calcium assays to rapidly rank offset rates, and predict in vivo coverage before you ever dose Suddenly, at higher doses, you see an exaggerated ‘bang’ of effect.
- Odorant receptors – a bit of smell for drug discovery
ORs are highly expressed by olfactory sensory neurons of the nose where they are activated by different analyses, have indicated that OR genes are also expressed in non-olfactory tissues including the testis, lung epithelial cells proliferation via activation by β-ionone which initiates prostate cancer cell cycle arrest (Jones In non-small-cell lung cancer OR2J3 activation induced apoptosis and inhibited cell proliferation and
- Michel Bouvier appointed Knight of the Ordre national du Québec
June 2022 "Published on juin 22, 2022 On June 22, 2022, Michel Bouvier, Chief Executive Officer of IRIC
- Crinetics Presents Clinical And Research Results At ENDO 2022
cortisol excretion in the presence of sustained, disease-like ACTH concentrations in multiple-ascending dose
- Addex raises $4.2 million in equity financing
development, today announced that it has entered into a definitive agreement with Armistice Master Fund Additionally, Addex has agreed to issue to Armistice Capital unregistered pre-funded warrants to purchase up to 11,700,000 shares in the form of 1,950,000 ADSs (the “Unregistered Pre-Funded Warrants”) at a funded amount of $1.69 with $0.01 payable on exercise as well as unregistered warrants to purchase up in the form of 2,500,000 ADSs (the “Unregistered Warrants” and together with the “Unregistered Pre-Funded
- Addex Raises $10 Million In Equity Financing
9,230,772 shares in the form of 1,538,462 ADSs (the “Unregistered Warrants”), as well as unregistered pre-funded warrants to purchase up to 5,478,570 shares in the form of 913,095 ADSs (the “Unregistered Pre-Funded The Unregistered Pre-Funded Warrants have been funded to the amount of $6.49 with $0.01 payable on exercise
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
1984 (Cerione et al. 1984), where reconstitution of purified β2-adrenergic receptors from guinea pig lung of adjustability in terms of pharmacological effects, allowing for the administration of substantial doses
- Structural perspectives on the mechanism of signal activation, ligand selectivity and allosteric...
Such studies revealed that tissue response to a given dose of the hormone or its antagonist depends on
- Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated
Ultimately this could lead to identification of new non-MOR targets that would allow for lower dose utilization
- Neuropeptide S Encodes Stimulus Salience in the Paraventricular Thalamus
The PVT appears to provide stimulus salience encoding in a dose- and NPS-dependent manner.
- Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
Cancer Research UK, a charity dedicated to funding lifesaving oncology research, spent £388 million on Much of that funding is distributed to support third party research, but the group also does its own
- Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare ...
2022 Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare Fund announced that the Company entered into a royalty-based financing with an affiliate of R-Bridge Healthcare Fund
- Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ...
million Tranche in Connection with its $40 million ex-US Royalty-Based Financing with R-Bridge Healthcare Fund million tranche from its royalty-based financing agreement with an affiliate of R-Bridge Healthcare Fund
- Platelets in the NETworks interweaving inflammation and thrombosis
immunothrombosis has become more relevant than ever, as a majority of COVID-19 patients display thrombi in the lung Furthermore, NETs can be found in the lung and other tissues and are associated with an increased mortality cytokine storm that potently activates neutrophils and leads to massive neutrophil infiltration into the lung
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
Investors don’t fund complexity. They fund momentum. When your team is aligned, you move faster without more funding. You adapt quicker without losing direction.
- From Technician to Trailblazer: How Sokhom Pin Designed His Own PhD Program While Working in Industry
How It Worked BMS funded the research, salary, and even tuition UConn accepted the research done in the
- Cell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation..
Pulmonary Fibrosis "Idiopathic pulmonary fibrosis (IPF) is a disease characterized by irreversible lung We demonstrate that OGR1 protein expression is significantly reduced in lung tissue from patients with
- Chemokine receptor-targeted drug discovery: progress and challenges
antibody mogamulizumab has also been approved in Japan and by the FDA for the treatment of mycosis fungoides molecular redundancy, pointing out that, in some cases, inappropriate target selection and insufficient dosing
- 4GPCRnet, September 26-29, 2022. Leipzig, Germany
Four of the biggest European networks on GPCR research (COST Actions Adher’n Rise and ERNEST plus DFG-funded
- Nanobodies: New Dimensions in GPCR Signaling Research
J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., Devree, B. T., Rosenbaum, D. M., Thian, F.
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
That kind of street-level data shapes everything: dosing strategies that reflect actual potencies in
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
dynamics of hM3Dq [Ca2+]i signaling, increased cell proliferation, and enhanced matrix production in a CNO dose
- Domain Therapeutics Raises $42m Series A Financing
$42m (€39m) series A financing round co-led by Panacea Venture, CTI Life Sciences and 3B Future Health Fund
- The sixth transmembrane region of a pheromone G-protein coupled receptor, Map3, is implicated in ...
In ascomycete fungi including yeasts, mating between cells of opposite mating type depends on the molecular
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben, Kuang, Wang & Kong, 2016; Kuang, Feng GPCR-related knowledge, AI can help identify patient-specific GPCR targets and optimize drug selection and dosing
- Curve Shifts Don’t Lie, But Your Eyes Might
Sometimes you’re working with linear fits: Schild plots, dose ratios, regression models.
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
US $900,000) of additional research funding.
- 4GPCRnet - International Symposium
Four of the biggest European networks on GPCR research (COST Actions Adher’n Rise and ERNEST plus DFG-funded







